Sana Biotechnology Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Sana Biotechnology Stock Summary

Sana Biotechnology competes with Olema Pharmaceuticals, Cullinan Oncology, Zentalis Pharmaceuticals, X4 Pharmaceuticals, and Terns Pharmaceuticals. Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company was incorporated in 2018 and is headquartered in Seattle, Washington. Sana Biotechnology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 461 people.

Sana Biotechnology Key Financial Ratios

Sana Biotechnology Key Balance Sheet Accounts

Sana Biotechnology Key Cash Accounts

Sana Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Sana Biotechnology's current stock value. Our valuation model uses many indicators to compare Sana Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sana Biotechnology competition to find correlations between indicators driving Sana Biotechnology's intrinsic value. More Info.Sana Biotechnology is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Sana Biotechnology's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sana Biotechnology's earnings, one of the primary drivers of an investment's value.

Sana Biotechnology Systematic Risk

Today, most investors in Sana Biotechnology Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Sana Biotechnology's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Sana Biotechnology growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Sana Biotechnology help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sana Biotechnology. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sana Biotechnology based on widely used predictive technical indicators. In general, we focus on analyzing Sana Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sana Biotechnology's daily price indicators and compare them against related drivers.

When running Sana Biotechnology's price analysis, check to measure Sana Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sana Biotechnology is operating at the current time. Most of Sana Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sana Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sana Biotechnology's price. Additionally, you may evaluate how the addition of Sana Biotechnology to your portfolios can decrease your overall portfolio volatility.